Mangoceuticals, Inc.

NasdaqCM:MGRX Stock Report

Market Cap: US$6.2m

Mangoceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:MGRX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Dec 25SellUS$3,884Eugene JohnstonIndividual3,333US$1.17
09 Dec 25SellUS$5,975Eugene JohnstonIndividual5,000US$1.20
05 Dec 25SellUS$11,280Eugene JohnstonIndividual10,000US$1.13
19 Nov 25SellUS$152,875Alexander HamiltonIndividual125,000US$1.22

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of MGRX?
Owner TypeNumber of SharesOwnership Percentage
Institutions826,9294.82%
Private Companies966,1905.63%
Individual Insiders2,771,70216.1%
General Public12,602,60173.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 48.9%.


Top Shareholders

Top 25 shareholders own 26.57% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.6%
Jacob Cohen
1,305,000US$469.0k0%no data
5.82%
Marvalyn Smith
1,000,000US$359.4k0%no data
3%
Greenfield Investments Ltd.
515,000US$185.1k0%no data
2.63%
Maab Global Limited
451,190US$162.2k0%no data
1.13%
Geode Capital Management, LLC
194,482US$69.9k79.5%no data
0.8%
Ikarian Capital, LLC
138,146US$49.6k0%0.01%
0.8%
Lorraine D’Alessio
136,667US$49.1k0%no data
0.8%
Kenny Myers
136,667US$49.1k0%no data
0.72%
Vanguard Capital Management, LLC
123,041US$44.2k0%no data
0.7%
Eugene Johnston
120,000US$43.1k0%no data
0.42%
Jane Street Group, LLC
72,746US$26.1k53.1%no data
0.36%
Virtu Financial, Inc.
61,028US$21.9k82.4%no data
0.35%
Antonios Isaac
60,000US$21.6k0%no data
0.33%
Vanguard Fiduciary Trust Company
57,163US$20.5k-17%no data
0.22%
Boothbay Fund Management, LLC
38,441US$13.8k0%no data
0.22%
Northern Trust Global Investments
37,579US$13.5k0%no data
0.2%
Ackerman Capital Advisors, LLC
34,500US$12.4k0%no data
0.093%
Sterne Agee Asset Management, Inc.
16,039US$5.8k0%no data
0.077%
XTX Markets Limited
13,142US$4.7k0%no data
0.07%
Sunbelt Securities, Inc.
12,000US$4.3k0%no data
0.068%
The Goldman Sachs Group, Inc.
11,757US$4.2k0%no data
0.068%
Amanda Hammer
11,668US$4.2k0%no data
0.058%
Csenge Advisory Group, LLC
10,000US$3.6k0%no data
0.019%
Osaic Wealth, Inc.
3,285US$1.2k13.9%no data
0.0099%
Alexander Hamilton
1,700US$610.8-49%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/09 00:33
End of Day Share Price 2026/07/09 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mangoceuticals, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.